CompoAtlas

EU YAN SANG AN SHEN JUN GING POWDER

EU YAN SANG AN SHEN JUN GING POWDER : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Dioscorea oppositaDioscorea opposita[54.4 mg,500 mg]Not identified
Poria cocosPoria cocos[34.7 mg,500 mg]Not identified
Atractylodes macrocephalaAtractylodes macrocephala[29.7 mg,500 mg]Not identified
Paeoniae albaPaeoniae alba[29.7 mg,500 mg]Not identified
Uncaria rhynchophyllaUncaria rhynchophylla[29.7 mg,500 mg]Not identified
Pogostemon cablinPogostemon cablin[29.7 mg,500 mg]Not identified
Bombyx moriBombyx mori[29.7 mg,500 mg]Not identified
Bupleurum chinenseBupleurum chinense[29.7 mg,500 mg]Not identified
Pinellia ternataPinellia ternata[29.7 mg,500 mg]Not identified
Bambusa textilisBambusa textilis[19.8 mg,500 mg]Not identified
Scutellaria baicalensisScutellaria baicalensis[24.8 mg,500 mg]Not identified
Mentha haplocalyxMentha haplocalyx[19.8 mg,500 mg]Not identified
Citrus reticulataCitrus reticulata[19.8 mg,500 mg]Not identified
Arisaema cum bileArisaema cum bile[19.8 mg,500 mg]Not identified
Notopterygium incisumNotopterygium incisum[14.8 mg,500 mg]Not identified
Gastrodia elataGastrodia elata[14.8 mg,500 mg]Not identified
Cryptotympana pustulataCryptotympana pustulata[14.8 mg,500 mg]Not identified
Glycyrrhiza uralensisGlycyrrhiza uralensis[14.8 mg,500 mg]Not identified
Gleditsia sinensisGleditsia sinensis[14.8 mg,500 mg]Not identified
Saposhnikovia divaricataSaposhnikovia divaricata[14.8 mg,500 mg]Not identified
SuccinumSuccinum[3.7 mg,500 mg]Not identified
Pteria martensiiPteria martensii[3.7 mg,500 mg]Not identified
Calculus bovisCalculus bovis[2.5 mg,500 mg]Not identified
Moschus moschiferusMoschus moschiferus[0.3 mg,500 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL18106127T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
EU YAN SANG (1959) SDN.BHD.
Manufacturer
WENG LI SDN. BHD.
Importer
NOT APPLICABLE
Registration period starting
2023-10-18
Published validity end
2028-10-18

Original register data

View published fields and their variants
Active ingredients
Dioscorea opposita[54.4 mg,500 mg],Poria cocos[34.7 mg,500 mg],Atractylodes macrocephala[29.7 mg,500 mg],Paeoniae alba[29.7 mg,500 mg],Uncaria rhynchophylla[29.7 mg,500 mg],Pogostemon cablin[29.7 mg,500 mg],Bombyx mori[29.7 mg,500 mg],Bupleurum chinense[29.7 mg,500 mg],Pinellia ternata[29.7 mg,500 mg],Bambusa textilis[19.8 mg,500 mg],Scutellaria baicalensis[24.8 mg,500 mg],Mentha haplocalyx[19.8 mg,500 mg],Citrus reticulata[19.8 mg,500 mg],Arisaema cum bile[19.8 mg,500 mg],Notopterygium incisum[14.8 mg,500 mg],Gastrodia elata[14.8 mg,500 mg],Cryptotympana pustulata[14.8 mg,500 mg],Glycyrrhiza uralensis[14.8 mg,500 mg],Gleditsia sinensis[14.8 mg,500 mg],Saposhnikovia divaricata[14.8 mg,500 mg],Succinum[3.7 mg,500 mg],Pteria martensii[3.7 mg,500 mg],Calculus bovis[2.5 mg,500 mg],Moschus moschiferus[0.3 mg,500 mg]
Valid until
2028-10-18
Registration date
2023-10-18
Published description
NATURAL PRODUCT
Licence holder
EU YAN SANG (1959) SDN.BHD.
Importer
NOT APPLICABLE
Producer
WENG LI SDN. BHD.
Published name
EU YAN SANG AN SHEN JUN GING POWDER
Published reference
201801081287T
Registration number
MAL18106127T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL18106127T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    Sources cited by Health Canada (1)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    Sources cited by Health Canada (2)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (4)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “EU YAN SANG AN SHEN JUN GING POWDER”, https://compoatlas.com/en/supplements/malaysia/MAL18106127T-eu-yan-sang-an-shen-jun-ging-powder, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line